Labeling single domain antibody fragments with
Breast cancer
Fluorine-18
HER2
Nanobody
Single domain antibody fragment
Journal
Nuclear medicine and biology
ISSN: 1872-9614
Titre abrégé: Nucl Med Biol
Pays: United States
ID NLM: 9304420
Informations de publication
Date de publication:
Historique:
received:
03
03
2021
revised:
09
06
2021
accepted:
09
06
2021
pubmed:
20
6
2021
medline:
21
1
2022
entrez:
19
6
2021
Statut:
ppublish
Résumé
Labeling single domain antibody fragments (sdAbs) with [ Radiochemical yields for the synthesis of Boc Although higher radiochemical yields than that reported for [
Identifiants
pubmed: 34146837
pii: S0969-8051(21)00484-4
doi: 10.1016/j.nucmedbio.2021.06.002
pmc: PMC8448961
mid: NIHMS1716046
pii:
doi:
Substances chimiques
Single-Domain Antibodies
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24-35Subventions
Organisme : NCI NIH HHS
ID : R01 CA042324
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188177
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA042324
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Michael R. Zalutsky holds ownership interest and is a board member for Cereius, Inc. Ganesan Vaidyanathan is a consultant and shareholder for Cereius, Inc. There are no other potential conflicts of interest relevant to this article.
Références
Bioconjug Chem. 2015 Jan 21;26(1):1-18
pubmed: 25473848
J Nucl Med. 2016 Jun;57(6):967-73
pubmed: 26912425
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11309-11314
pubmed: 29073049
J Natl Cancer Inst. 2018 Jun 1;110(6):568-580
pubmed: 29315431
Molecules. 2013 May 10;18(5):5335-47
pubmed: 23666002
J Immunol Methods. 1984 Aug 3;72(1):77-89
pubmed: 6086763
Bioconjug Chem. 2014 May 21;25(5):979-88
pubmed: 24815083
Mol Imaging Biol. 2017 Dec;19(6):867-877
pubmed: 28409338
Mol Carcinog. 2006 Sep;45(9):667-75
pubmed: 16652376
Bioconjug Chem. 2001 May-Jun;12(3):428-38
pubmed: 11353542
Curr Radiopharm. 2009 Jan 1;2(1):63-74
pubmed: 20414475
Nucl Med Biol. 2019 Apr;71:19-22
pubmed: 31128474
J Nucl Med. 2013 May;54(5):776-84
pubmed: 23487015
Nucl Med Biol. 2013 Jan;40(1):52-9
pubmed: 23159171
Angew Chem Int Ed Engl. 2021 Jan 25;60(4):1797-1805
pubmed: 33047860
Org Lett. 2020 Feb 7;22(3):804-808
pubmed: 31927933
Org Biomol Chem. 2016 Jan 28;14(4):1261-71
pubmed: 26645790
Tumour Biol. 2012 Jun;33(3):607-15
pubmed: 22270450
Bioconjug Chem. 2018 Dec 19;29(12):4090-4103
pubmed: 30384599
Nucl Med Biol. 2014 Nov-Dec;41(10):802-12
pubmed: 25156548
Curr Opin Oncol. 2010 Nov;22(6):559-66
pubmed: 20842031
Chem Soc Rev. 2015 Aug 7;44(15):5495-551
pubmed: 26000775
FASEB J. 2011 Jul;25(7):2433-46
pubmed: 21478264
Chem Rev. 2016 Jan 27;116(2):719-66
pubmed: 26751274
Anticancer Res. 2018 Oct;38(10):6023-6026
pubmed: 30275235
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661
pubmed: 27847991
Biomaterials. 2016 Sep;100:143-51
pubmed: 27258484
Theranostics. 2014 Apr 25;4(7):708-20
pubmed: 24883121
Stem Cells. 2015 Oct;33(10):2985-94
pubmed: 26260958
Nat Protoc. 2007;2(2):282-6
pubmed: 17406587
Front Pharmacol. 2018 Mar 27;9:266
pubmed: 29636685
European J Org Chem. 2019 Feb 28;2019(8):1722-1725
pubmed: 31007573
Tumour Biol. 2012 Jun;33(3):669-77
pubmed: 22392499
Mol Pharm. 2020 Sep 8;17(9):3553-3566
pubmed: 32787284
Tetrahedron Lett. 2015 Feb 7;56(7):952-954
pubmed: 26989269
Bioorg Med Chem. 2018 May 1;26(8):1939-1949
pubmed: 29534937
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2300-2306
pubmed: 30058029
Bioorg Med Chem. 2020 Sep 1;28(17):115634
pubmed: 32773089
Semin Cancer Biol. 2018 Oct;52(Pt 1):56-73
pubmed: 28882552
Mol Pharm. 2018 Apr 2;15(4):1457-1466
pubmed: 29502411
Semin Cancer Biol. 2021 Jul;72:185-197
pubmed: 33465471
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1697
pubmed: 33470555
J Nucl Med. 2010 Jul;51(7):1049-58
pubmed: 20554737
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1371-1389
pubmed: 33179151
Cancer Rep (Hoboken). 2020 Sep 3;:e1274
pubmed: 32881421
EJNMMI Res. 2021 Jan 19;11(1):6
pubmed: 33464410
Mol Pharm. 2016 May 2;13(5):1668-78
pubmed: 27010700
Pathol Int. 2016 Jun;66(6):313-24
pubmed: 27061008
Mol Imaging. 2020 Jan-Dec;19:1536012120960258
pubmed: 32957830
Nat Protoc. 2011 Oct 13;6(11):1718-25
pubmed: 22011654
Cancer Lett. 2018 Apr 10;419:139-151
pubmed: 29414302
Nucl Med Biol. 2018 Jan;56:10-20
pubmed: 29031230
Cancer Res. 2000 Aug 15;60(16):4453-60
pubmed: 10969792
Small. 2019 Nov;15(48):e1901551
pubmed: 31207085
ACS Chem Biol. 2017 Jun 16;12(6):1478-1483
pubmed: 28445029
Mol Pharm. 2019 Jan 7;16(1):214-226
pubmed: 30427188